baber/WOPTO huggingface dataset:
Patent AU-744221-B2 (AU)
Title: Electrofusion coupler
Inventor: ANDERSSON THOMAS
IPC: F16L47/02
Filed: 1999-03-05
Granted: 2002-02-21
Abstract: A fusion welding socket (18) for coupling together plastic pipes, is adapted to receive the pipe parts to be coupled together with a tight fit. The diameter of the ends (19) of the socket is greater than the diameter of the socket along an intermediate part (20) and the diameter at the ends is adapted to receive with a tight fit an outer pipe (1) and the diameter of the intermediate part is adapted to receive with a tight fit an inner pipe (2) of a double-pipe conduit which includes two coaxial pipes and a leakage detection space (3) therebetween. The socket includes coils (24-27) having resistance wires or filaments which enable the socket material to be fused locally together with the material in both the outer pipes and the inner pipes of two double-pipe conduits that are to be coupled together with the aid of the socket. The socket also includes at least one passageway (21) which interconnects the spaces in the socket on both sides of the intermediate socket part.
Patent AU-767230-B2 (AU)
Title: Identifying golf balls
Inventor: JOLLIFFE STEVEN PAUL
IPC: G06F17/00
Filed: 1999-03-19
Granted: 2003-11-06
Abstract: In a golf driving range (10, FIG. 1 not shown) golf balls (21) incorporating uniquely-coded passive transponders are collected by means of a device having a receiving channel (22) which directs the balls past a reader (25) employing RFID technology which reads the codes and supplies this information via a link (32) to a central computer for subsequent display. The reader (25) also actuates a gate (28) to direct the balls to a "reject" receptacle (29) or an "accept" receptacle (30). Similar devices are used for dispensing golf balls (50, FIG. 4 not shown) or supplying balls to an automatic tee device (70, FIG. 5 not shown). Alternatively balls can be identified on or near a tee (84, FIGS. 6 and 7 not shown) on a mat (70).
Patent AU-690311-B2 (AU)
Title: Novel process for the production of biologically active dimeric protein
Inventor: CERLETTI NICO
IPC: C07K14/495
Filed: 1995-07-12
Granted: 1998-04-23
Abstract: The present invention relates to a folding process for the preparation of biologically active, dimeric TGF- beta  (Tranforming Growth Factor type  beta )-like protein.
Patent AU-682278-B2 (AU)
Title: Oligomer carrier molecules in which marker groups and haptens are selectively incorporated
Inventor: JOSEL HANS-PETER
IPC: G01N33/543
Filed: 1995-07-24
Granted: 1997-09-25
Abstract: The present invention concerns novel conjugates, process for manufacturing them, and the use of such conjugates as antigens in immunological detection processes or in DNA diagnostic procedures.
Patent AU-764017-B2 (AU)
Title: Unscrambling and aligning conveyor
Inventor: PELKA RONALD E
IPC: B65G47/244
Filed: 2000-02-22
Granted: 2003-08-07
Abstract: A feed system that is adapted for feeding articles to a sortation system includes at least one feed conveyor upstream of the sortation system feeding articles to the sortation system. The feed conveyor includes a plurality of side rails extending from an initial portion of the feed conveyor to a terminal portion thereof. The side rails are spaced apart a substantially constant distance from the initial portion to the terminal portion to provide a footprint that is substantially the footprint of a transport conveyor. A conveying surface is provided between the side rails. The conveying surface includes at least one article-transporting portion and at least one article-unscrambling portion. The portions are in tandem. The unscrambling portion is made up of a plurality of tapered rollers mounted between the side rails.
Patent AU-729684-B2 (AU)
Title: The NucA protein of Haemophilus influenzae and the gene encoding that protein
Inventor: ZAGURSKY ROBERT JOHN
IPC: A61P31/16
Filed: 1997-07-23
Granted: 2001-02-08
Abstract: A protein from H. influenzae designated NucA is isolated and purified. The NucA protein has the amino acid sequence of amino acids 26-603 of SEQ ID NO.2 or a biologically equivalent amino acid sequence thereof. Amino acids 1-25 of SEQ ID NO.2 are the signal peptide, which is cleaved during processing of the mature protein. The NucA protein has a molecular weight of approximately 63,000 Daltons as measured on a 12% SDS-PAGE gel and possesses 5'-nucleotidase activity. The NucA protein is obtained by isolation and purification from the H. influenzae organism, by chemical synthesis or by recombinant expression by an isolated and purified nucA DNA sequence which encodes the NucA protein. Such a DNA sequence hybridizes under standard high stringency Southern hybridization conditions with a DNA sequence encoding the NucA protein of H. influenzae having the amino acid sequence of amino acids 26-603 of SEQ ID NO.2 or a biologically equivalent amino acid sequence thereof. The NucA protein is used to prepare a vaccine composition which elicits a protective immune response in a mammalian host to protect the host against disease caused by H. influenzae.
Patent AU-627766-B2 (AU)
Title: Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs
Inventor: ARANDA JULIAN
IPC: C07D213/69
Filed: 1989-08-04
Granted: 1992-09-03
Abstract: The invention concerns new derivatives of certain alkoxy-4(1H)-pyridones, processes for preparing them, and pharmaceutical compositions containing them. The compounds of the invention are useful in the prevention and/or treatment of heart and blood vessel diseases such as thromboses, arteriosclerosis and hypertension, and of inflammatory processes, allergies, cancers, and certain degenerative damage of the central nervous system.
Patent AU-760350-B2 (AU)
Title: Craft with tilting sail
Inventor: DUNCAN DAVID
IPC: B63H9/06
Filed: 2000-06-14
Granted: 2003-05-15
Abstract: A single or multi-hulled sailing craft has a stub mast 5 upstanding from the hull. A sail 10 has a luff edge 11 secured to a luff boom 20 and a foot edge 12 secured to a foot boom 21 which is connected to the lower end of the luff boom. Part way along the luff boom 20 a pivotal fitting 22 connects the luff boom to the stub mast 5, and a rigid swing boom 26 is pivotally connected between the foot boom 21 and the hull or the stub mast. The fitting 22 can be moved up and down the stub mast 5 by means of a tilt sheet. The swing boom can be connected to a carriage which moves transversely of the hull. The sail is self-tacking and its position is positively controlled to prevent collision of the sail with the stub mast.  <IMAGE>
Patent AU-660102-B2 (AU)
Title: Metal scavengers and processes for the production thereof
Inventor: MORIYA MASAFUMI
IPC: B01J20/26
Filed: 1993-07-20
Granted: 1995-06-08
Abstract: The present invention provides metal scavengers and processes for the production thereof. The metal scavenger has a structure that is formed by replacing the hydrogen atoms linked to the nitrogen atoms of a polyamine having aminomethyl groups by dithioic acid groups or their salts and that is represented by the following general formula:   <CHEM> wherein R represents a dithioic acid group, an alkali metal dithioate group, an alkaline earth metal dithioate group, or an ammonium dithioate group and R' represents a hydrogen atom, a dithioic acid group, an alkali metal dithioate group, an alkaline earth metal dithioate group, or an ammonium dithioate group.
Patent AU-676168-B2 (AU)
Title: Truncated tissue factor and FVIIa or FVII activator for blood coagulation
Inventor: MORRISSEY JAMES H
IPC: A61P7/04
Filed: 1993-05-12
Granted: 1997-03-06
Abstract: It has been discovered that it is possible to administer truncated tissue factor (not having the transmembrane region) (tTF) in combination with factor VIIa (FVIIa) or an activator of endogenous factor VII to treat bleeding disorders such as those resulting from hemophilia or cirrhosis of the liver. The tTF is administered to produce up to 10  mu g tTF/ml of plasma. The FVIIa or FVII activator is administered to produce levels of between 40 ng FVIIa/ml and 700 ng FVIIa/ml of plasma. The effective dosages of both tTF and FVIIa/factor VII activator are significantly and surprisingly less than the administration of either alone to stop bleeding. Examples demonstrate safety and efficacy in normal and hemophilic dogs.
Patent AU-619621-B2 (AU)
Title: Pipe interrupter
Inventor: OBERDORFER HANS
IPC: E03C1/10
Filed: 1989-11-20
Granted: 1992-01-30
Abstract: A pipe interrupter, which is particularly suitable for installation in a sanitary fitting, comprises in a housing a chamber, into which a water-supply passage, a water-discharge passage and a ventilation path open. Located in the chamber is a rolling membrane, which is fixed at the peripheral region. Normally, thus as long as there is no reduced pressure in the supply passage, the rolling membrane bears in the central region against the opening aperture of the ventilation path in the chamber, so that on the one hand no atmospheric air may enter and on the other hand no water may escape. However, if reduced pressure occurs in the pipe system, which is connected to the supply passage, then the rolling membrane overturns so that now on the opposite side of the central region it closes the opening point of the supply passage into the chamber. On the other side, a ventilation path to the chamber is exposed. This ventilation path continues by way of a through-flow opening in the edge region of the rolling membrane towards the discharge passage. In this way, water can no longer flow back into the supply passage and into the pipe system connected thereto; on the other hand, the water-ways following the chamber are ventilated.
Patent AU-688736-B2 (AU)
Title: Interleukin-4 stimulated T lymphocyte cell death
Inventor: LENARDO MICHAEL J
IPC: A61K35/12
Filed: 1993-08-10
Granted: 1998-03-19
Abstract: This invention discloses a method for the treatment or prevention of autoimmune diseases, allergic or atopic disorders and graft rejection. Specifically, it provides a means of killing a specific sub-population of T lymphocytes while leaving the majority of other T lymphocytes in the population unaffected. The sub-population of T lymphocytes are killed by repeatedly challenging the population with an antigen in conjunction with administration of interleukin-4.
Patent AU-531617-B2 (AU)
Title: Processes for production of conveyor belts
Inventor: LITCHFIELD PETER JOHN
IPC: B29D29/00
Filed: 1979-11-22
Granted: 1983-09-01
Abstract: Solid woven conveyor belting is produced by a process which includes the step of subjecting the fabriccarcase(5)to a plurality of alternating changes of direction whilst immersed in a bath (14) of impregnant materials (15), each of said changes of direction being effected by causing the carcase to follow a generally curved path whose radius of curvature is appreciably less than 75 mm. Prior to immersion, a synthetic polymeric yarn-containing carcase may be subjected to a shrinking treatment (10) effective to shrink at least the synthetic fibre component of the carcase.
Patent AU-616352-B2 (AU)
Title: Processes for preparing 1,5-benzothiazepine derivatives
Inventor: NISHIMOTO SHIGERU
IPC: C07D281/10
Filed: 1990-04-26
Granted: 1991-10-24
Abstract: There is disclosed a process for preparing 1,5-benzothiazepine derivatives represented by the formula: <CHEM> wherein one of R<1> and R<2> is a lower alkyl group or halogen atom, and the other is hydrogen atom, R<3> is a lower alkyl group or a lower alkoxy group, which comprises subjecting a propionic acid compound represented by the formula (II): <CHEM> wherein R<1>, R<2> and R<3> have the same meanings as defined above,  to intramolecular ring closing reaction in the presence of a sulfonic acid compound represented by the formula (III):    R<5>SO3H   (III> wherein R<5> represents a lower alkyl group or a substituted or unsubstituted phenyl group.
Patent AU-624502-B2 (AU)
Title: Barrel injector screw
Inventor: KOENIG LARRY
IPC: B02C19/22
Filed: 1990-04-30
Granted: 1992-06-11
Abstract: An auger shredder and feeder system includes a primary housing (10) for receiving material to be ground and shredded. A primarily auger (60) is rotatably mounted within a grinding chamber (14) formed in the housing. An extrusion tube (30) receives material ground and shredded within the grinding chamber. A secondary housing (44) having a generally tubular side wall communicates with the extrusion tube (30). A secondary auger (72) is rotatably mounted within the secondary housing (44). Material deposited in the primary housing is crushed and shredded, then pumped by the primary auger (60) through the extrusion tube (30) where it forms a plug of material. As the plug progresses into the secondary housing (44), it is further shredded and compressed by the secondary auger (72).
Patent AU-533548-B2 (AU)
Title: Door closer
Inventor: CHADDOCK DENNIS HILLIAR
IPC: E05F3/12
Filed: 1980-03-18
Granted: 1983-12-01
Abstract: A door closer includes a tension member comprising spaced shafts acted by springs and connected to articulated chains which are coupled to an anchor plate secured to the door frame. Movement of the shafts is under the control of a uni-directionally operative fluid-filled damper having a piston carried by a piston rod which is connected to a cross head slidably mounted on the shafts and held against abutment washers by the springs. The damper serves to regulate the rate of movement of a door in the direction of closure without restricting significantly the rate of movement in the direction of opening. A fluid by-pass is provided in the damper by a rebate formed in the cylinder so that as the piston approaches the end of the cylinder over the final part of the closure movement the restraint imposed by the damper is relieved. The point in the closure movement at which the fluid by-pass becomes operative can be varied while the closer is installed so as to provide compensation for variations in the installation of the closer and variations of the gap between the door and its frame. In one embodiment this is achieved by securing the chains to an adjustment plate which is movable towards and away from the anchor plate. In another embodiment the piston rod is adjustable secured to the cross head, which in this case is in the form of a stirrup with a cross member on which the piston rod is carried presented towards and accessible from the outer end of the housing so as to enable the piston rod to be adjusted.
Patent AU-687371-B2 (AU)
Title: Microporous macrocapsules
Inventor: GENTILE FRANK T
IPC: A61K9/50
Filed: 1993-11-16
Granted: 1998-02-26
Abstract: A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.
Patent AU-635745-B2 (AU)
Title: Improved process for manufacturing dairy products
IPC: A23C19/09
Filed: 1990-06-06
Granted: 1993-04-01
Abstract: Improved process for the manufacture of dairy products, characterised in that it comprises using an effective quantity of at least one of the gluconic and glucoheptonic ions not later than the time at which the phage attack is liable to take place.
Patent AU-635286-B2 (AU)
Title: Aqueous liquid composition for external use
IPC: C07H19/01
Filed: 1990-07-03
Granted: 1993-03-18
Abstract: An aqueous liquid composition for external use characterized in that the composition contains a tricyclo compound of the formula: <CHEM> wherein the substituents have certain definitions, particularly 17-Allyl-1,14,dihydroxy-12[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylv inyl]-23,2 5-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo-[22.3.1. 0<4,9</ SP>]octacos-18-ene-2,3,10,16-tetraone], and process for preparing it.
Patent AU-705488-B2 (AU)
Title: Controlled release of drugs delivered by sublingual or buccal administration
Inventor: EL-RASHIDY RAGAB
IPC: A61K31/485
Filed: 1996-06-13
Granted: 1999-05-20
Abstract: A composition providing a relatively slow release of water-soluble drugs, such as apomorphine, for delivery via the sublingual or buccal routes.
Patent AU-668465-B2 (AU)
Title: Peptidic detones as interleukin-1beta-converting enzyme inhibitors
Inventor: DOLLE ROLAND E
IPC: C07C271/22
Filed: 1994-05-06
Granted: 1996-05-02
Abstract: Disclosed are compounds of formula (I) and pharmaceutically acceptable salts thereof: <CHEM>  wherein R1 is (CR5R6)n, (CR5R6)n-aryl, (CR5R6)n-heteroaryl, X-(CR5R6)n, X-(CR5R6)n-aryl or X-(CR5R6)n-heteroaryl wherein aryl and heteroaryl may be optionally substituted;     X is O or NR5;     R5 and R6 are independently H or lower alkyl;     R2 is H, halo, lower alkyl or (CR5R6)n-aryl;     R3 and R4 are independently H or alkyl; A is a D or L isomer of an amino acid selected from the group consisting of alanine, valine, leucine, isoleucine, proline, phenylalanine, glycine, tyrosine, methionine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine, histidine and  beta -thienylalanine;     Z is CH2 or O; and     n is 0-4; pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta  protease activity in a mammal utilizing the compounds and compositions.
Patent AU-591938-B2 (AU)
Title: Liquid, phytoactive compositions and methods of use
Inventor: CHAN JIMMY HUA-HIN
IPC: A01N25/30
Filed: 1986-10-20
Granted: 1989-12-21
Abstract: A liquid phytoactive composition characterised in that it comprises;  (a) an N-phosphonomethyl-N-carboxymethyl compound;  (b) one or more liquid nonionic surfanctants; (c) a dispersing medium for the said N-phosphonomethyl-N-carboxymethyl compound; and  (d) one or more inert adjuvants is disclosed. A liquid herbicidal concentrate characterised in that it comprises: (a) an herbicidally effective N-phosphonomethyl-N-carboxymethyl compound  (b) one or more liquid nonionic surfactants; (c) a solvent for the said N-phosphonomethyl-N-carboxymethyl compound; and  (d) one or more inert adjuvants  is also disclosed. The formulation of this invention has the advantage that it can contain a high amount of active ingredient, is thermally stable over a wide temperature range, is compatible with and dilutable in both hard and soft water, and is also compatible and dilutable with a nitrogeneous fertilizer solution, and is minimally irritable to the eyes. Also, the formulation of this invention is stable upon aging over months of storage, over a wide temperature range. In addition, the nonionic surfactants are derived from naturally occurring products and are readily broken down by microorganisms.
Patent AU-640446-B2 (AU)
Title: Apparatus and method for providing credit for operating a gaming machine
IPC: G06Q20/04
Filed: 1990-12-19
Granted: 1993-08-26
Abstract: The apparatus for enabling a gaming machine in an establishment to provide credit to a player operating the machine without the player leaving the machine. The gaming machine has a card reader associated with it for transmitting player related financial data to a remote location for approval. A first code identifies the particular gaming machine and a second code identifies the establishment in which the gaming machine is located. A visual display on the gaming machine indicates the amount of credit approved and usable by the player and enables the player to operate the gaming machine to use the credit.
Patent AU-726454-B2 (AU)
Title: Arrangement in a two cycle combustion engine with internal combustion
Inventor: HENRIKSEN LEIF DAG
IPC: F02B75/32
Filed: 1998-04-22
Granted: 2000-11-09
Abstract: The internal combustion engine has a plurality of cylinders which are arranged in an annular series about a common central drive shaft. Each cylinder includes a pair of opposed pistons which are movable towards and away from each other while defining a combustion chamber therebetween. Each piston is connected to a piston rod which causes rotation of a cam guide device secured to the drive shaft. Each cam guide device has a curved cam surface having portions in phase-displaced relation to the curved cam surface of the other cam guide device as well as portions in mutually-phased relation. The cam surfaces each have a rectilinear portion to define a stationary combustion chamber for combustion between the pistons of each cylinder. The cam guide devices also have portions to permit opening of the exhaust ports prior to opening of the air scavaging ports of the cylinder.
Patent AU-678598-B2 (AU)
Title: Catalysts for low temperature cure of blocked isocyanates
Inventor: BOSSERT EMILY CAROL
IPC: C09D175/00
Filed: 1994-07-26
Granted: 1997-06-05
Abstract: The present invention comprises a curable composition comprising: (i) a blocked reactive component comprising a blocked isocyanate or a blocked isothiocyanate; (ii) a functional compound containing reactive hydrogen; (iii) a triorganotin catalyst for promoting the reaction of the blocked reactive component with the functional compound. The composition may also be admixed with water. The invention also relates to a method for curing a blocked isocyanate or blocked isothiocyanate at a temperature below about 150 DEG  C. which comprises combining a triorganotin compound with the blocked reactive component and functional compound and heating at a temperature less than about 150 DEG  C. to obtain a cured urethane or thiourethane.
Patent AU-774215-B2 (AU)
Title: Optical fiber distribution frame with connector modules
Inventor: PUETZ CURTIS LEE
IPC: G02B6/44
Filed: 2000-05-25
Granted: 2004-06-17
Abstract: A fiber optic termination module comprising a housing (632) having first and second spaced apart ends (710, 712), and first and second spaced apart sides (714,716) extending between the ends. The housing includes a rear (718) extending between the first and second ends and the first and second sides to define an interior, defining an open front (720) bounded by the first and second ends and the first and second sides. The first and second ends (710, 712) extend generally horizontally when the termination module (632) is mounted to a telecommunications rack (1320), the first and second sides (714, 716) extending generally vertically when the termination module (632) is mounted to the telecommunications rack (1320), and the housing includes a cable access opening (715) for accessing the interior through one of the sides. A main panel (724) is mounted to the open front (720), and includes an array of openings arranged and sized for holding adapters (134), the adapters being sized for mounting to cable connectors. The main panel (724) is positioned at a nonperpendicular angle relative to the rear (718), the sides (714, 716) being positioned at a generally perpendicular angle relative to the rear (718).
Patent AU-770503-B2 (AU)
Title: Ultrasonic medical device operating in a transverse mode
Inventor: RABINER ROBERT A
IPC: A61B18/00
Filed: 2000-09-29
Granted: 2004-02-26
Abstract: An ultrasonic medical device comprises an ultrasonic vibration generator that generates vibration along its longitudinal axis. The ultrasonic vibration is transmitted through an ultrasonic coupler and a series of transformer sections that amplify the ultrasonic vibration. A flexible member is coupled to the distal end of the transformer sections, and is thus supplied with a longitudinal vibration at its base by the transformer sections. The flexible member is designed so that it converts the longitudinal vibration into a standing wave that runs along the length of the flexible member. The standing wave produces a series of nodes and anti-nodes along the length of the flexible member. Each of the anti-nodes produces cavitation in fluids in contact with the probe. The cavitation of the fluids causes destruction of adjacent tissue. In this manner, the entire length of the flexible member becomes a working surface that may be utilized for destroying tissue.